Circio Holding ASA
@targovax.com
Circio Holding ASA (OSE:TRVX, to be changed to CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines.
Circio Holding ASA's Company Logos
Circio Holding ASA's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#5843A0
Gigas
88, 67, 160
254, 41, 45
45, 58, 0, 37
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#240D55
Violent Violet
36, 13, 85
259, 73, 19
58, 85, 0, 67
About Circio Holding ASA
Targovax, formerly known as Circio Holding ASA (OSE:TRVX, to be changed to CRNA), is a leading biotechnology company focused on the development of innovative circular RNA and immunotherapy medicines. With a strong emphasis on cutting-edge research and development, Targovax aims to activate the patient's immune system to effectively combat cancer, providing much-needed treatment options for patients facing limited alternatives. The company has a robust pipeline of clinical programs, including ONCOS-102 and the KRAS program, which have shown promising results in challenging cancer types.
Targovax is committed to delivering value to its shareholders and is dedicated to solving critical unmet medical needs through its circular RNA platform. With a dedicated team of experienced professionals and a commitment to scientific excellence, Targovax is poised to revolutionize the field of RNA therapeutics and make a significant impact in the fight against cancer. Stay connected with Targovax to stay informed about the latest breakthroughs and advancements in this exciting field
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
11-50 employees
